These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25825623)

  • 1. Sustained release of hydrophobic drugs by the microfluidic assembly of multistage microgel/poly (lactic-co-glycolic acid) nanoparticle composites.
    Hsu MN; Luo R; Kwek KZ; Por YC; Zhang Y; Chen CH
    Biomicrofluidics; 2015 Sep; 9(5):052601. PubMed ID: 25825623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells.
    Kavas A; Keskin D; Altunbaş K; Tezcaner A
    Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of three-arm block copolymer poly(lactic-
    Zhu X; Liu C; Duan J; Liang X; Li X; Sun H; Kong D; Yang J
    Int J Nanomedicine; 2016; 11():6065-6077. PubMed ID: 27895480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro IFN-α release from IFN-α- and pegylated IFN-α-loaded poly(lactic-co-glycolic acid) and pegylated poly(lactic-co-glycolic acid) nanoparticles.
    Feczkó T; Fodor-Kardos A; Sivakumaran M; Haque Shubhra QT
    Nanomedicine (Lond); 2016 Aug; 11(16):2029-34. PubMed ID: 27462975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controllable delivery of hydrophilic and hydrophobic drugs from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats.
    Song B; Wu C; Chang J
    J Biomed Mater Res B Appl Biomater; 2012 Nov; 100(8):2178-86. PubMed ID: 22887492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrophobic ion pairing of a minocycline/Ca(2+)/AOT complex for preparation of drug-loaded PLGA nanoparticles with improved sustained release.
    Holmkvist AD; Friberg A; Nilsson UJ; Schouenborg J
    Int J Pharm; 2016 Feb; 499(1-2):351-357. PubMed ID: 26773599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ethylene glycol)-poly(lactic-co-glycolic acid) core-shell microspheres with enhanced controllability of drug encapsulation and release rate.
    Cha C; Jeong JH; Kong H
    J Biomater Sci Polym Ed; 2015; 26(13):828-40. PubMed ID: 26063500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of flash nanoprecipitation to fabricate poorly water-soluble drug nanoparticles.
    Tao J; Chow SF; Zheng Y
    Acta Pharm Sin B; 2019 Jan; 9(1):4-18. PubMed ID: 30766774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Assembly of Click-Nucleic-Acid-Containing PEG-PLGA Nanoparticles for DNA Delivery.
    Harguindey A; Domaille DW; Fairbanks BD; Wagner J; Bowman CN; Cha JN
    Adv Mater; 2017 Jun; 29(24):. PubMed ID: 28397966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of sialoadhesin-expressing macrophages through antibody-conjugated (polyethylene glycol) poly(lactic-co-glycolic acid) nanoparticles.
    Van Hees S; Elbrink K; De Schryver M; Delputte P; Kiekens F
    J Nanopart Res; 2022; 24(3):65. PubMed ID: 35311024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin.
    Samkange T; D'Souza S; Obikeze K; Dube A
    J Pharm Pharmacol; 2019 Oct; 71(10):1497-1507. PubMed ID: 31385295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of β-Sitosterol Loaded PLGA and PEG-PLA Nanoparticles for Effective Treatment of Breast Cancer: Preparation, Physicochemical Characterization, and Antitumor Activity.
    Andima M; Costabile G; Isert L; Ndakala AJ; Derese S; Merkel OM
    Pharmaceutics; 2018 Nov; 10(4):. PubMed ID: 30445705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of 6-Thioguanine conjugated PLGA nanoparticles through thioester bond formation: Benefits of electrospray mediated drug encapsulation and sustained release in cancer therapeutic applications.
    Chatterjee M; Jaiswal N; Hens A; Mahata N; Chanda N
    Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111029. PubMed ID: 32994006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microneedle-mediated intradermal nanoparticle delivery: Potential for enhanced local administration of hydrophobic pre-formed photosensitisers.
    Donnelly RF; Morrow DI; Fay F; Scott CJ; Abdelghany S; Singh RR; Garland MJ; Woolfson AD
    Photodiagnosis Photodyn Ther; 2010 Dec; 7(4):222-31. PubMed ID: 21112544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone.
    Liu J; Zeng Y; Shi S; Xu L; Zhang H; Pathak JL; Pan Y
    Int J Nanomedicine; 2017; 12():3561-3575. PubMed ID: 28507436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, evaluation, and
    Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
    Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.
    Lin TsT; Gao DY; Liu YC; Sung YC; Wan D; Liu JY; Chiang T; Wang L; Chen Y
    J Control Release; 2016 Jan; 221():62-70. PubMed ID: 26551344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.